Management of spasticity in children: Part 1: Chemical denervation

Journal of Head Trauma Rehabilitation

Volumn 14, Issue 1, 1999, Pages 97-99

  Gormley Jr , Mark E ^a,b  

^a GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PHENOL;

ARTICLE; CHILD; CHILD DEVELOPMENT; DENERVATION; DYSESTHESIA; HUMAN; INFLUENZA; LETHAL DOSE; NEUROLYSIS; SPASTICITY;

EID: 0344096646     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-199902000-00013     Document Type: Article

References (10)

1. Traboulsi E, Maumenee I. Eye problems. In: Oski FA, ed. Principles and Practice of Pediatrics. Philadelphia, Pa: JB Lippincott; 1990.
2. Helwag-Larson J, Jacobsen E. Treatment of spasticity in cerebral palsy by means of phenol nerve block of peripheral nerves. Dan Med Bull, 1969;16:20-25.
3. Carpenter E, Seitz D. Intramuscular alcohol as an aid in the management of spastic cerebral palsy. Dev Med Child Neurol. 1980;22:497-501.
4. Griffith E, Melampy C. General anesthesia use in phenol intramuscular neurolysis in young children with spasticity. Arch Phys Med Rehabil. 1977;58:154-157.
5. Sutherland D, et al. Injection of botulinum A toxin into gastrocnemius muscle of patients with cerebral palsy: A 3D motion analysis study (Class A). Gait posture. 1996;4(4):269-279.
6. Borodic G, et al. Pharmacology and histology of the therapeutic application of botulinum toxin. In: Jakovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker; 1994.
7. Glenn M. Nerve blocks. In: Glenn M, Whyte J, eds. The Practical Management of Spasticity in Children and Adults. Philadelphia, Pa: Lea & Febiger; 1990.
8. Russman B, Tilton A, Gormley M. Cerebral palsy: A rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve. 1997;86:S181-S193.
9. Scott A, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Movement Disord. 1988;9(2):213-217.
10. Gormley M, Herring G, Gaebler-Spira D. The use of botulinum toxin in children: A retrospective study of adverse reactions and treatment of idiopathic toe-walking. Eur J Neurol. 1997;4(Suppl 2):S27-S30.